50
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9623 |
RORγt inverse agonist 13
|
ROR | Metabolism |
RORγt inverse agonist 13 是一种口服有效的RORγt 选择性反向激动剂,IC50为 63.8 nM。 | |||
T12753 |
RORγt Inverse agonist 6
|
ROR | Metabolism |
RORγt Inverse agonist 6 是 RORγt inverse 的激动剂。 RORγt Inverse agonist 6 可用于研究 Th17 驱动的自身免疫性疾病。 | |||
T39038 | RORγt inhibitor 1 | ||
RORγt inhibitor 1 is a RORγt allosteric inhibitor with an IC 50 value of 1 nM. | |||
T40043 |
RORγt Inverse agonist 10
|
||
RORγt Inverse agonist 10 is a highly potent and orally bioavailable compound that acts as an antagonist for the retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt). With an IC50 of 51 nM, it effectively inhibits the activity of RORγt, a prominent transcription factor involved in the regulation of genes associated with the pathogenesis of psoriasis, including IL-17A, IL-22, and IL-23R. | |||
T39720 |
RORγt inverse agonist 23
|
||
RORγt inverse agonist 23, an orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist, is a potent and selective RORγt inverse agonist. | |||
T12751 | RORγt agonist 1 | Others | Others |
RORγt agonist 1 is a potent, orally bioavailable agonist of RORγt(EC50 of 20.8 nM). | |||
T12754 |
RORγt Inverse agonist 8
|
ROR | Metabolism |
RORγt Inverse agonist 8 is a potent, selective, orally bioavailable RORγt inverse agonist(human RORγt-LBD with an IC50 of 19 nM). | |||
T12752 |
RORγt Inverse agonist 3
|
Others | Others |
RORγt Inverse agonist 3 is a potent, selective and orally active inverse agonist of RORγ(EC50s of 0.22 μM and 0.15 μM for hRORγ and RORγt (human IL-17 cells), respectively). | |||
T12755 |
RORγt Inverse agonist 2
|
Others | Others |
RORγt Inverse agonist 2 is a selective, orally active inverse agonist of RORγt(EC50 of 119 nM). | |||
T63124 | RORγt modulator 4 | ||
RORγt modulator 4 是一种 RORγt 调节剂。RORγt modulator 4 能够调节源自小鼠脾脏的细胞中 IL-17A 产生的活性。 | |||
T72596 |
RORγt modulator 5
|
||
RORγt modulator 5 是一种 RORγt 调节剂,Ki 值 <100 nM。RORγt modulator 5 可用于研究 RORy 介导的炎症、代谢、自身免疫和其他疾病。 | |||
T63678 |
RORγt modulator 2
|
||
RORγt modulator 2 是一种类视黄醇相关孤儿受体 γt (RORyt) 的调节剂 (IC50<50 nM),能够用于 RORγt 介导的疾病的研究,如疼痛、炎症、哮喘、类风湿性关节炎、COPD、多发性硬化、银屑病、结肠炎、神经退行性疾病和癌症。 | |||
T64017 |
RORγt agonist 3
|
||
RORγt agonist 3 是 RORγt 的有效激动剂。RORγt agonist 3 能够促使 Th17 细胞分化,增加促炎细胞因子水平,进而提高淋巴细胞的细胞毒性。RORγt agonist 3 能够阻碍调节性 T 细胞的产生,并免疫反应产生抑制作用。 | |||
T64140 |
RORγt agonist 2
|
||
RORγt agonist 2 是 RORγt 的有效的激动剂。RORγt agonist 2 能够诱导 Th17 细胞分化,增加促炎细胞因子水平,进而增强淋巴细胞的细胞毒性。RORγt agonist 2 对调节性 T 细胞的产生表现出抑制作用,能够抑制免疫反应。 | |||
T72595 |
RORγt inhibitor 2
|
||
RORγt inhibitor 2 是一种有效的RORγt 抑制剂,IC50为 9.2 nM。RORγt inhibitor 2可用于研究由RORγt 介导的癌症、炎症或自身免疫性疾病。 | |||
T63609 | RORγt modulator 3 | ||
RORγt modulator 3 是一种类视黄醇相关孤儿受体 γt (RORγt) 的调节剂,能够用于研究 RORγt 介导的疾病,如疼痛、COPD、炎症、哮喘、结肠炎、多发性硬化、类风湿性关节炎、银屑病、神经退行性疾病和癌症。 | |||
T63874 | RORγt inverse agonist 28 | ||
RORγt inverse agonist 28 是有效的 RORγt 反向激动剂。RORγt inverse agonist 28 能够调节 Th17 细胞的分化,并抑制 IL-17 的产生。RORγt inverse agonist 28 对炎症和自身免疫性疾病表现出研究潜力。 | |||
T64145 | RORγt/DHODH-IN-1 | ||
RORγt/DHODH-IN-1 (compound (R)-14d) 是一种有效的、口服具有活力 RORγt (IC50: 0.083 μM) 和 DHODH (IC50: 0.172 μM) 的双重抑制剂。RORγt/DHODH-IN-1 具有明显的体内抗炎作用。 | |||
T62564 |
RORγt inverse agonist 30
|
||
RORγt inverse agonist 30 (Compound 1) 是一种有效的 RORγt 反向激动剂 (IC50: 46 nM)。靶向核受体 RORγt 能够有效治疗自身免疫性疾病。 | |||
T64146 | RORγt/DHODH-IN-3 | ||
RORγt/DHODH-IN-3 (compound (S)-14d) 是一种有效的、口服具有活力 RORγt (IC50: 0.098 μM) 和 DHODH (IC50: 0.432 μM) 的双重抑制剂。RORγt/DHODH-IN-1 具有明显的体内抗炎作用。 | |||
T79470 |
RORγt inverse agonist 31
|
ROR | Metabolism |
RORγt inverse agonist 31 (14g) 为一有效RORγt反向激动剂,具备0.428 μM的IC50值。该化合物能够缓解Imiquimod诱发的小鼠牛皮癣症状。 | |||
T62462 | RORγt/DHODH-IN-2 | ||
RORγt/DHODH-IN-2 (compound 1) 是一种有效的 RORγt/DHODH 双重抑制剂,能够用于研究炎症性肠病 (IBD)。 | |||
T72254 |
RORγt inverse agonist 26
|
||
RORγt inverse agonist 26 是一种有效的 RORγt 反向激动剂。RORγt inverse agonist 26 调节 Th17 细胞的分化并抑制 IL-17的产生。RORγt inverse agonist 26 具有研究炎症和自身免疫性疾病的潜力。 | |||
T62956 | RORγt inverse agonist 29 | ||
RORγt inverse agonist 29 是一种有效的、选择性的、口服具有活力的 RORγt 反向激动剂,其 IC50 值为 21 nM。RORγt inverse agonist 29 能够用于皮肤炎症和银屑病等自身免疫性疾病的研究。 | |||
T72252 | RORγt inverse agonist 14 | ROR | Metabolism |
RORγt inverse agonist 14 (8e) 是一种高效、口服活性及选择性 RORγt 反向激动剂(EC50 为 2.5 nM),具有抗炎作用,主要应用于风湿性关节炎和牛皮癣的研究。 | |||
T16832 |
S18-000003
|
ROR | Metabolism |
S18-000003 是口服有活性的维甲酸相关孤儿受体 (RORγt) 选择性抑制剂,在竞争性结合试验中,对 hRORγt 的 IC50值小于 30 nM。它对 RORγt 的选择性比其他 ROR 家族成员 (IC50>10 μM)更高。它可用于银屑病的研究,胸腺畸变风险较低。 | |||
T9635 |
Cedirogant
ABBV-157 |
ROR | Metabolism |
Cedirogant (ABBV-157) 是一种口服有活性的 RORγt 反向激动剂,可用于研究银屑病。 | |||
T4670 |
SR0987
|
ROR | Metabolism |
SR0987是SR1078 的类似物,是RORγt 的激动剂,其EC50=800 nM。它可上调IL17 的表达,并且抑制PD-1 的表达。 | |||
T13172L1 |
TMP-778
|
ROR | Metabolism |
TMP-778是一种RORγt 的选择性逆向激动剂。 | |||
T39250 |
Bevurogant
|
ROR | Metabolism |
Bevurogant 是 RORγt 受体的拮抗剂,可用于治疗慢性炎症性疾病的研究。 | |||
T37587 |
ML 209
|
ROR | Metabolism |
ML-209 是一种视黄酸相关的孤儿受体 RORγ 拮抗剂 (IC50= 1.1 μM)。ML-209 抑制 HEK293t 细胞中 RORγt 转录活性(IC50= 300 nM)。ML-209 不抑制细胞中 RORα。ML-209 对鼠 Th17 细胞分化具有选择性抑制,而不影响幼稚 CD4+ T 细胞分化为 Th1 和调节性 T 细胞。 | |||
T7388 |
GSK805
|
ROR | Metabolism |
GSK805 是能够生物利用的、具有 CNS 穿透性的 RORγt 抑制剂。 | |||
T24984 |
5J-4
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
5J-4 是一种有效的钙释放激活钙通道 (CRAC) 和钙池操纵性钙内流(SOCE) 阻滞剂。 5J-4 减少 IL-17 的产生并降低 RORα 和 RORγt 的表达。 | |||
T5163 |
SR1001
|
ROR | Metabolism |
SR1001 是选择性RORα及RORγt 的反向激动剂,其Ki 分别为 172 和 111 nM。 | |||
T13172 | TMP780 | ROR | Metabolism |
TMP780 is an inverse RORγt agonist (IC50: 13 nM). RORγt is a tractable drug target for the treatment of cutaneous inflammatory disorders. | |||
T17108 |
TMP920
|
ROR | Metabolism |
TMP920 inhibits RORγt binding to the SRC1 peptide (IC50: 0.03 μM). TMP920 is a highly potent and selective RORγt antagonist. | |||
T13067 | TAK-828F | ROR | Metabolism |
TAK-828F is a potent, selective, and orally available retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist (IC50=1.9 nM, reporter gene IC50=6.1 nM). | |||
T11308 |
FM26
|
ROR | Metabolism |
FM26 has a distinct isoxazole chemotype and effectively reduces IL-17a mRNA production in EL4 cells. FM26 is a potent and allosteric retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists with an IC50 of 264 nM. | |||
T40123 | BMS-986251 | ||
BMS-986251 is a potent and specific RORγt inverse agonist that exerts its action via oral administration. It shows an EC 50 of 12 nM for RORγt GAL4. In human whole blood assay, BMS-986251 effectively inhibits IL-17 with an EC 50 of 24 nM. Furthermore, BMS-986251 exhibits strong therapeutic effects in mouse acanthosis and Imiquimod-induced models, which are commonly used preclinical models for psoriasis. | |||
T10210 |
A-9758
|
ROR | Metabolism |
A-9758 is a RORγ ligand and a selective RORγt inverse agonist (IC50: 5 nM) and exhibits robust potency against IL-17A release. It is effective in suppressing both Th17 differentiation and Th17 effector function. A-9758 significantly attenuates IL-23 drive | |||
T69770 |
BMS-986313
|
||
BMS-986313 is a RORγt Inverse Agonist with RORγt EC50 = 3.6 nM and WB EC50 = 50 nM. | |||
T25557 |
JNJ-3534
JNJ 3534,JNJ3534 |
||
JNJ-3534 is an oral active modulator of RORγt. | |||
T13172L | TMP778 | Others | Others |
TMP778 is an effective and selective RORγt inverse agonist (IC50: 7 nM in FRET assay). | |||
T23793 |
BIO399
BIO 399 |
||
BIO399 is an agonist of the RORγt inverse. | |||
T23794 |
BIO592
BIO-592,BIO 592 |
||
BIO592 is a modulator of RORγt. BIO592 triggers inverse agonism of RORγ. | |||
T24727 |
ROR Modulator I
ROR-Modulator-I,RORModulatorI |
||
ROR Modulator I is the first potent inverse agonist of the retinoid-related orphan receptor. It also has dual selectivity for RORβ and RORγt. | |||
T36998 |
7β,27-dihydroxy Cholesterol
7β,27-DHC,7β,27-dihydroxy Cholesterol |
||
7β,27-dihydroxy Cholesterol is an oxysterol and agonist of retinoic acid receptor-related orphan receptor γ (RORγ) and RORγt. [1] It activates RORγ- or RORγt-dependent signaling with EC50 values of 691 and 1,045 nM, respectively, in reporter assays using HEK293T cells expressing the recombinant human receptors. 7β,27-dihydroxy Cholesterol is selective for RORγ and RORγt over a panel of eight additional nuclear receptors at 30 µM. It increases IL-17A production in Th17-polarized isolated hum... | |||
T70065 |
JNJ-61803534
|
||
JNJ-61803534 是一种有效的、具有口服活性 RORγt 反向激动剂,IC50为 9.6 nM。JNJ-61803534 具有抗炎活性。JNJ-61803534 在 Th17 分化条件下抑制人 CD4+ T 细胞产生 IL-17A。 | |||
T62622 |
MRL-871
|
||
MRL-871 (compound 3) 是一种有效的异生维甲酸受体相关孤儿受体 γt (RORγt) 反向激动剂 (IC50: 264 nM)。MRL-871 表现出独特的异恶唑化学型,可有效减少 EL4 细胞中 IL-17a mRNA 的产生。 | |||
T64300 | Vimirogant hydrochloride | ||
Vimirogant (VTP-43742) hydrochloride 是一种口服具有活力的、选择性的 RORγt 抑制剂 (IC50: 17 nM, Ki: 3.5 nM),选择性比 RORα 和 RORβ 大于 1000 倍。Vimirogant hydrochloride 能够抑制小鼠脾细胞的 Th17 分化和 IL-17A 分泌,其 IC50 值为 57 nM,且不影响 Th1,Th2 或 Treg 细胞的分化。Vimirogant hydrochloride 能够用于自身免疫性疾病的研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13502 |
3-Oxo-5β-cholanoic acid
3-氧代-5β-胆烷酸,Dehydrolithocholic acid |
ROR | Metabolism |
3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid) 是胆汁酸的一种代谢产物。3-Oxo-5β-cholanoic acid 直接与关键转录因子RORγt(Kd=1.13 μM) 结合抑制TH17细胞分化。 |